The Characteristics of Trigeminal Neuralgia Treatment Methods

Abstract

Pain is a crucial clinical, social and economical problem. Patients with trigeminal neuralgia, making up about 15-20% of all peripheral nervous system diseases, are especially suffering with pain. Trigeminal neuralgia -highly intensive sharp pain in one or both sides of the face. The disorder is caused by an inflammation of the trigeminal nerve (nervus trigeminus), the fifth cranial nerve composed of three branches. We compared trigeminal neuralgia treatment methods, that are used for patients hospitalised in

The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review

“…No information was found on comparison of BT-A therapy with surgical methods. It is possible to compare our data with the research of Leketas et al[35], which states that surgical treatment results in a 27.53 month remission. Less efficient are pharmacotherapy, resulting in a 15.51 month remission.…”